Skip to main content

MediWound Ltd.

MDWD
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001593984

In the last 90 days, MediWound Ltd. insiders filed 1 open-market purchase and 2 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $85.5M in total; ARK Invest is the only superinvestor holding it.

Q4 2022 vs. Q3 2022

How the institutions holding MediWound Ltd. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of MDWD: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders2819−9
SharesConverted for a 1-for-7 split1.25M815.9K−431.8K (−34.6%)
Value$12.2M$11.0M−$1.18M (−9.7%)

New holders (3)

Institutions that held MediWound Ltd. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to MDWD in Q4 2022
InstitutionSharesValue% of portfolio
The PNC Financial Services Group, Inc.4,229$57.0K0.00%
UBS Group AG1,514$20.4K0.00%
JPMorgan Chase & Co2$00.00%

Sold out (12)

Institutions that held MediWound Ltd. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of MDWD in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Armistice Capital, LLC1,915,520$2.66M
We Are One Seven, LLC64,100$89.0K
Millennium Management LLC40,664$57.0K
Thomasville National Bank31,000$43.0K
Acadian Asset Management LLC20,010$27.0K
Geode Capital Management, LLC18,827$26.0K
Susquehanna International Group, LLP17,175$24.0K
LPL Financial LLC13,159$18.0K
Pathstone Family Office, LLC10,000$13.9K
MUFG Americas Holdings Corp1,600$2.00K
Geneos Wealth Management Inc.1,500$2.00K
Bank of America Corp314$0